Question 1

What are the potential side effects of HKI-272?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating HKI-272 in Tumors clinical trial (NCT00146172). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating HKI-272 in Tumors clinical trial (NCT00146172). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating HKI-272 in Tumors clinical trial (NCT00146172). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating HKI-272 in Tumors clinical trial (NCT00146172). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific eligibility criteria I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating HKI-272 in Tumors clinical trial (NCT00146172). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating HKI-272 in Tumors clinical trial (NCT00146172). Contact the study team or your healthcare provider for specific answers.

What this study is about